St. Petersburg | Moscow | Czech Republic | Turkey | Beijing | Valencia | Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N = 2715 | N = 1400 | N = 79 | N = 614 | N = 1149 | N = 3657 | N = 9614 | ||||||||
Characteristic | n | % | n | % | n | % | n | % | n | % | n | % | n | % |
Age in years, median (range) | 3 (0–94) | 19 (0–90) | 51 (19–91) | 12 (0–98) | 8 (0–96) | 73 (0–106) | 21 (0–106) | |||||||
Age group | ||||||||||||||
0–1 y | 714 | 26.3 | 137 | 9.8 | 0 | 0.0 | 112 | 18.2 | 76 | 6.6 | 476 | 13.0 | 1515 | 15.8 |
2–4 y | 1034 | 38.1 | 371 | 26.5 | 0 | 0.0 | 133 | 21.7 | 403 | 35.1 | 265 | 7.2 | 2206 | 22.9 |
5–17 y | 357 | 13.1 | 171 | 12.2 | 0 | 0.0 | 80 | 13.0 | 147 | 12.8 | 72 | 2.0 | 827 | 8.6 |
18–49 y | 426 | 15.7 | 632 | 45.1 | 38 | 48.1 | 38 | 6.2 | 106 | 9.2 | 221 | 6.0 | 1461 | 15.2 |
50–64 y | 110 | 4.1 | 59 | 4.2 | 14 | 17.7 | 75 | 12.2 | 131 | 11.4 | 359 | 9.8 | 748 | 7.8 |
65–74 y | 39 | 1.4 | 13 | 0.9 | 12 | 15.2 | 69 | 11.2 | 93 | 8.1 | 593 | 16.2 | 819 | 8.5 |
75–84 y | 31 | 1.1 | 11 | 0.8 | 9 | 11.4 | 80 | 13.0 | 127 | 11.1 | 969 | 26.5 | 1227 | 12.8 |
≥85 y | 4 | 0.1 | 6 | 0.4 | 6 | 7.6 | 27 | 4.4 | 66 | 5.7 | 702 | 19.2 | 811 | 8.4 |
Sex | ||||||||||||||
M | 1489 | 54.8 | 827 | 59.1 | 40 | 50.6 | 356 | 58.0 | 696 | 60.6 | 2009 | 54.9 | 5417 | 56.3 |
F | 1226 | 45.2 | 573 | 40.9 | 39 | 49.4 | 258 | 42.0 | 453 | 39.4 | 1648 | 45.1 | 4197 | 43.7 |
Chronic conditions | ||||||||||||||
0 | 2380 | 87.7 | 1246 | 89.0 | 29 | 36.7 | 182 | 29.6 | 820 | 71.4 | 1210 | 33.1 | 5867 | 61.0 |
1 | 244 | 9.0 | 116 | 8.3 | 31 | 39.2 | 196 | 31.9 | 233 | 20.3 | 1026 | 28.1 | 1846 | 19.2 |
&;1 | 91 | 3.4 | 38 | 2.7 | 19 | 24.1 | 236 | 38.4 | 96 | 8.4 | 1421 | 38.9 | 1901 | 19.8 |
Previously hospitalised (last 12months) | ||||||||||||||
N | 1781 | 65.6 | 1123 | 80.2 | 56 | 70.9 | 341 | 55.5 | 964 | 85.1 | 2491 | 68.1 | 6756 | 70.4 |
Y | 934 | 34.4 | 277 | 19.8 | 23 | 29.1 | 273 | 44.5 | 169 | 14.9 | 1166 | 31.9 | 2842 | 29.6 |
Underlying chronic conditions | ||||||||||||||
Cardiovascular disease | 140 | 5.2 | 68 | 4.9 | 29 | 36.7 | 215 | 35.0 | 218 | 19.0 | 1328 | 36.3 | 1998 | 20.8 |
Chronic obstructive pulmonary disease | 51 | 1.9 | 19 | 1.4 | 6 | 7.6 | 153 | 24.9 | 137 | 11.9 | 1093 | 29.9 | 1459 | 15.2 |
ٳ | 60 | 2.2 | 19 | 1.4 | 3 | 3.8 | 74 | 12.1 | 8 | 0.7 | 282 | 7.7 | 446 | 4.6 |
Immunodeficiency/organ transplant | 30 | 1.1 | 0 | 0.0 | 3 | 3.8 | 48 | 7.8 | 0 | 0.0 | 25 | 0.7 | 106 | 1.1 |
Dٱ | 32 | 1.2 | 14 | 1.0 | 12 | 15.2 | 96 | 15.6 | 34 | 3.0 | 860 | 23.5 | 1048 | 10.9 |
Renal impairment | 18 | 0.7 | 26 | 1.9 | 4 | 5.1 | 61 | 9.9 | 12 | 1.0 | 485 | 13.3 | 606 | 6.3 |
Neuromuscular disease | 68 | 2.5 | 15 | 1.1 | 1 | 1.3 | 79 | 12.9 | 12 | 1.0 | 92 | 2.5 | 267 | 2.8 |
NDZ | 7 | 0.3 | 9 | 0.6 | 9 | 11.4 | 79 | 12.9 | 7 | 0.6 | 190 | 5.2 | 301 | 3.1 |
Cirrhosis/liver disease | 34 | 1.3 | 21 | 1.5 | 5 | 6.3 | 19 | 3.1 | 5 | 0.4 | 118 | 3.2 | 202 | 2.1 |
Autoimmune disease | 13 | 0.5 | 14 | 1.0 | 4 | 5.1 | 22 | 3.6 | 0 | 0.0 | 122 | 3.3 | 175 | 1.8 |
Pregnant (women 15–45 y) | 0 | 0.0 | 291 | 95.7 | 1 | 7.1 | 1 | 4.8 | 0 | 0.0 | 5 | 5.7 | 298 | 45.4 |
Obese (all ages) | 263 | 9.7 | 162 | 11.6 | 12 | 15.2 | 109 | 17.8 | 155 | 13.5 | 957 | 26.2 | 1658 | 17.2 |
Outpatient consultations last 3months | ||||||||||||||
0 | 1215 | 44.8 | 492 | 35.1 | 23 | 29.1 | 113 | 18.4 | 4 | 0.3 | 649 | 17.7 | 2496 | 26.0 |
1 | 895 | 33.0 | 314 | 22.4 | 19 | 24.1 | 100 | 16.3 | 697 | 60.9 | 678 | 18.5 | 2703 | 28.1 |
&;1 | 605 | 22.3 | 594 | 42.4 | 37 | 46.8 | 401 | 65.3 | 443 | 38.7 | 2330 | 63.7 | 4410 | 45.9 |
Smoking habits (patients ≥18 y) | ||||||||||||||
Never smoker | 325 | 53.3 | 345 | 47.9 | 40 | 50.6 | 135 | 46.7 | 269 | 51.4 | 1363 | 47.9 | 2477 | 48.9 |
Past smoker | 76 | 12.5 | 136 | 18.9 | 19 | 24.1 | 117 | 40.5 | 162 | 31 | 1034 | 36.4 | 1544 | 30.5 |
Current smoker | 209 | 34.3 | 240 | 33.3 | 20 | 25.3 | 37 | 12.8 | 92 | 17.6 | 447 | 15.7 | 1045 | 20.6 |
Functional status impairment (Barthel score; patients ≥65 y) | ||||||||||||||
Total (0–15) | 1 | 1.4 | 0 | 0.0 | 3 | 11.1 | 6 | 3.4 | 23 | 10.0 | 166 | 7.3 | 199 | 7.1 |
Severe (20–35) | 1 | 1.4 | 0 | 0.0 | 1 | 3.7 | 3 | 1.7 | 19 | 8.3 | 71 | 3.1 | 95 | 3.4 |
Moderate (40–55) | 1 | 1.4 | 1 | 3.3 | 1 | 3.7 | 6 | 3.4 | 37 | 16.1 | 140 | 6.2 | 186 | 6.6 |
Mild (60–90) | 25 | 33.8 | 6 | 20.0 | 9 | 33.3 | 76 | 43.2 | 136 | 59.1 | 414 | 18.3 | 666 | 23.8 |
Minimal (95–100) | 46 | 62.2 | 23 | 76.7 | 13 | 48.1 | 85 | 48.3 | 15 | 6.5 | 1473 | 65.1 | 1655 | 59.1 |
Sampling time | ||||||||||||||
0–2 days | 1351 | 49.8 | 655 | 46.8 | 20 | 25.3 | 125 | 20.4 | 324 | 28.2 | 896 | 24.5 | 3371 | 35.1 |
3–4 days | 915 | 33.7 | 523 | 37.4 | 26 | 32.9 | 213 | 34.7 | 382 | 33.2 | 1572 | 43.0 | 3631 | 37.8 |
5–7 days | 449 | 16.5 | 221 | 15.8 | 24 | 30.4 | 239 | 38.9 | 358 | 31.2 | 1058 | 28.9 | 2349 | 24.4 |
8–9 days | 0 | 0.0 | 1 | 0.1 | 9 | 11.4 | 37 | 6.0 | 85 | 7.4 | 131 | 3.6 | 263 | 2.7 |
Influenza vaccination ≥14days from symptom onset | 59 | 2.2 | 39 | 2.8 | 1 | 1.3 | 28 | 4.6 | 127 | 11.1 | 1759 | 48.1 | 2013 | 20.9 |